| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |